NLRP3 and type 2 diabetes mellitus: Previous studies revealed the activation of nucleotide-binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome in DM patients via a ROS-mediated pathway [34], which would impair wound healing in mice and humans with type 2 diabetes [35].